New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide

Daily 20-μg and once-weekly 56.5-μg teriparatide (parathyroid hormone 1–34) treatment regimens increase bone mineral density (BMD) and prevent fractures, but changes in bone turnover markers differ between the two regimens. The aim of the present study was to explain changes in bone turnover markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Sakae, Adachi, Taiji, Kuroda, Tatsuhiko, Nakamura, Toshitaka, Shiraki, Masataka, Sugimoto, Toshitsugu, Takeuchi, Yasuhiro, Saito, Mitsuru, Bilezikian, John P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472137/
https://www.ncbi.nlm.nih.gov/pubmed/26273530
http://dx.doi.org/10.1038/boneres.2014.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472137/
https://www.ncbi.nlm.nih.gov/pubmed/26273530
http://dx.doi.org/10.1038/boneres.2014.43

Ejemplares similares